4-48510152-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015030.2(FRYL):c.8301G>T(p.Met2767Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000666 in 1,610,536 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015030.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FRYL | NM_015030.2 | c.8301G>T | p.Met2767Ile | missense_variant | 59/64 | ENST00000358350.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FRYL | ENST00000358350.9 | c.8301G>T | p.Met2767Ile | missense_variant | 59/64 | 5 | NM_015030.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000526 AC: 80AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000418 AC: 104AN: 249078Hom.: 0 AF XY: 0.000422 AC XY: 57AN XY: 135114
GnomAD4 exome AF: 0.000680 AC: 992AN: 1458334Hom.: 1 Cov.: 28 AF XY: 0.000646 AC XY: 469AN XY: 725696
GnomAD4 genome AF: 0.000526 AC: 80AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.000498 AC XY: 37AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.8301G>T (p.M2767I) alteration is located in exon 59 (coding exon 56) of the FRYL gene. This alteration results from a G to T substitution at nucleotide position 8301, causing the methionine (M) at amino acid position 2767 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at